Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira‐Silva, Gwen Falony, Eugeni Belda, et al.
Nature (2020) Vol. 581, Iss. 7808, pp. 310-315
Open Access | Times Cited: 373

Showing 1-25 of 373 citing articles:

Gut microbiota in human metabolic health and disease
Yong Fan, Oluf Pedersen
Nature Reviews Microbiology (2020) Vol. 19, Iss. 1, pp. 55-71
Open Access | Times Cited: 3166
Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 573-599
Open Access | Times Cited: 289
The Healthy Microbiome—What Is the Definition of a Healthy Gut Microbiome?
Fergus Shanahan, Tarini Shankar Ghosh, Paul W. O’Toole
Gastroenterology (2020) Vol. 160, Iss. 2, pp. 483-494
Closed Access | Times Cited: 263
The long-term genetic stability and individual specificity of the human gut microbiome
Lianmin Chen, Daoming Wang, Sanzhima Garmaeva, et al.
Cell (2021) Vol. 184, Iss. 9, pp. 2302-2315.e12
Open Access | Times Cited: 257
Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis
Mariona Pinart, Andreas Dötsch, Kristina Schlicht, et al.
Nutrients (2021) Vol. 14, Iss. 1, pp. 12-12
Open Access | Times Cited: 247
Systems biology in cardiovascular disease: a multiomics approach
Abhishek Joshi, Marieke Rienks, Konstantinos Theofilatos, et al.
Nature Reviews Cardiology (2020) Vol. 18, Iss. 5, pp. 313-330
Closed Access | Times Cited: 199
Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease
Francesco Violi, Vittoria Cammisotto, Simona Bartimoccia, et al.
Nature Reviews Cardiology (2022) Vol. 20, Iss. 1, pp. 24-37
Open Access | Times Cited: 184
Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology
Antonio Molinaro, Pierre Bel Lassen, Marcus Henricsson, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 183
Microbiome and metabolome features of the cardiometabolic disease spectrum
Sébastien Fromentin, Sofia K. Forslund, Kanta Chechi, et al.
Nature Medicine (2022) Vol. 28, Iss. 2, pp. 303-314
Open Access | Times Cited: 171
Combinatorial, additive and dose-dependent drug–microbiome associations
Sofia K. Forslund, Rima Chakaroun, Maria Zimmermann‐Kogadeeva, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 500-505
Closed Access | Times Cited: 166
Mucosal immunity–mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer’s patches
Sisi Lin, Subhajit Mukherjee, Juanjuan Li, et al.
Science Advances (2021) Vol. 7, Iss. 20
Open Access | Times Cited: 163
Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure
Jonel Trebicka, Peer Bork, Aleksander Krag, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 3, pp. 167-180
Closed Access | Times Cited: 145
Temporal variability in quantitative human gut microbiome profiles and implications for clinical research
Doris Vandeputte, Lindsey De Commer, Raúl Y. Tito, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 142
Gut Microbial Ecosystem in Parkinson Disease: New Clinicobiological Insights from Multi‐Omics
Ai Huey Tan, Chun Wie Chong, Shen‐Yang Lim, et al.
Annals of Neurology (2020) Vol. 89, Iss. 3, pp. 546-559
Closed Access | Times Cited: 140
Gut microbiota in patients with obesity and metabolic disorders — a systematic review
Zhilu Xu, Wei Jiang, Wenli Huang, et al.
Genes & Nutrition (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 135
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota
Anna E. Lindell, Maria Zimmermann‐Kogadeeva, Kiran Raosaheb Patil
Nature Reviews Microbiology (2022) Vol. 20, Iss. 7, pp. 431-443
Open Access | Times Cited: 133
Probiotics, prebiotics, and postbiotics in health and disease
Jing Ji, Weilin Jin, Shuang‐Jiang Liu, et al.
MedComm (2023) Vol. 4, Iss. 6
Open Access | Times Cited: 127
The Gut Microbiome in Hypertension
Ellen G. Avery, Hendrik Bartolomaeus, András Maifeld, et al.
Circulation Research (2021) Vol. 128, Iss. 7, pp. 934-950
Open Access | Times Cited: 124
Dynamics of the normal gut microbiota: A longitudinal one-year population study in Sweden
Lisa Olsson, Fredrik Boulund, Staffan Nilsson, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 5, pp. 726-739.e3
Open Access | Times Cited: 119
The promise of the gut microbiome as part of individualized treatment strategies
Daniel Schupack, Ruben A. T. Mars, Dayne Voelker, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 19, Iss. 1, pp. 7-25
Open Access | Times Cited: 110
Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease
Baolei Jia, Yuanqiang Zou, Xiao Han, et al.
Trends in Microbiology (2022) Vol. 31, Iss. 1, pp. 76-91
Closed Access | Times Cited: 107
Mining microbes for mental health: Determining the role of microbial metabolic pathways in human brain health and disease
Simon Spichak, Thomaz F. S. Bastiaanssen, Kirsten Berding, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 698-761
Open Access | Times Cited: 106
Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism
Eugeni Belda, Lise Voland, Valentina Tremaroli, et al.
Gut (2022) Vol. 71, Iss. 12, pp. 2463-2480
Open Access | Times Cited: 94
The human gut microbiota and glucose metabolism: a scoping review of key bacteria and the potential role of SCFAs
Marie Palmnäs-Bédard, Giuseppina Costabile, Claudia Vetrani, et al.
American Journal of Clinical Nutrition (2022) Vol. 116, Iss. 4, pp. 862-874
Open Access | Times Cited: 92
Microbiota-derived tryptophan catabolites mediate the chemopreventive effects of statins on colorectal cancer
Ji‐Xuan Han, Zhi‐Hang Tao, Jilin Wang, et al.
Nature Microbiology (2023) Vol. 8, Iss. 5, pp. 919-933
Open Access | Times Cited: 89
Page 1 - Next Page

Scroll to top